Found 142 matching trials
Hypofractionated Chemoradiotherapy for Cervical Cancer PHASE3 The goal of this clinical trial is to evaluate whether hypofractionated who...
Show More Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Hypoxia-targeted Radiotherapy Boost for GBM NA The purpose of this study is to evaluate the use of dynamic contrast-enhanc...
Show More Location
NYU Langone Health
Learn More & Join Trial
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors NA Hepatic metastases are common in solid cancers (up to 30% of patients with ...
Show More Status
Active Not Recruiting
Location
Centre Georges François Leclerc
Learn More & Join Trial
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer PHASE2 To improve the survival in patients with microsatellite stable metastatic c...
Show More Learn More & Join Trial
Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer N/A This is a multicenter, randomized, controlled phase III trial to evaluate t...
Show More Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Learn More & Join Trial
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers NA After surgery to remove the main endometrial and/or cervical tumor, most wo...
Show More Location
University of California at Los Angeles
Learn More & Join Trial
Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma PHASE2 Patients with advanced pancreas adenocarcinoma will be randomized on a 6:1 ...
Show More Status
Active Not Recruiting
Location
Washington University School of Medicine
Learn More & Join Trial
Adaptive Immunotherapy for Nasopharyngeal Carcinoma PHASE3 1. To assess whether radiotherapy alone is non-inferior to concurrent chemo...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
MRI - Guided Adaptive RadioTHerapy for Dysphagia in Head and Neck Cancer NA Recently developed hybrid machines (MRidian®-CE approval since 2016), consi...
Show More Location
Sichuan Cancer Hospital and Research Institute
Learn More & Join Trial